Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Obach

Showing results (1-10 of 193) with videos related to

Pageof 20
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2009
Glycerolysis of acyl glucuronides as an artifact of in vitro drug metabolism incubationsR Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2022
Linezolid Metabolism Is Catalyzed by Cytochrome P450 2J2, 4F2, and 1B1R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
Potent inhibition of human liver aldehyde oxidase by raloxifeneR Scott Obach
Current Topics in Medicinal Chemistry|February 16, 2011
Predicting clearance in humans from in vitro dataR Scott Obach
Pharmacological Reviews|February 15, 2013
Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapyR Scott Obach
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Drug-drug interactions: an important negative attribute in drugsR Scott Obach
Current Opinion in Drug Discovery & Development|January 20, 2009
Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advancesR Scott Obach
Current Drug Metabolism|March 26, 2011
Addressing MIST (Metabolites in Safety Testing): bioanalytical approaches to address metabolite exposures in humans and animalsHongying Gao, R Scott Obach
Current Drug Metabolism|June 23, 2007
Drug-drug interactions via mechanism-based cytochrome P450 inactivation: points to consider for risk assessment from in vitro data and clinical pharmacologic evaluationKarthik Venkatakrishnan, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2016
Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 EnzymesHeather Eng, R Scott Obach
Pageof 20

Showing results (1-10 of 193) with videos related to

Sort By:
Pageof 20
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 15, 2009
Glycerolysis of acyl glucuronides as an artifact of in vitro drug metabolism incubationsR Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 19, 2022
Linezolid Metabolism Is Catalyzed by Cytochrome P450 2J2, 4F2, and 1B1R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 8, 2004
Potent inhibition of human liver aldehyde oxidase by raloxifeneR Scott Obach
Current Topics in Medicinal Chemistry|February 16, 2011
Predicting clearance in humans from in vitro dataR Scott Obach
Pharmacological Reviews|February 15, 2013
Pharmacologically active drug metabolites: impact on drug discovery and pharmacotherapyR Scott Obach
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
Drug-drug interactions: an important negative attribute in drugsR Scott Obach
Current Opinion in Drug Discovery & Development|January 20, 2009
Predicting drug-drug interactions from in vitro drug metabolism data: challenges and recent advancesR Scott Obach
Current Drug Metabolism|March 26, 2011
Addressing MIST (Metabolites in Safety Testing): bioanalytical approaches to address metabolite exposures in humans and animalsHongying Gao, R Scott Obach
Current Drug Metabolism|June 23, 2007
Drug-drug interactions via mechanism-based cytochrome P450 inactivation: points to consider for risk assessment from in vitro data and clinical pharmacologic evaluationKarthik Venkatakrishnan, R Scott Obach
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 9, 2016
Use of Human Plasma Samples to Identify Circulating Drug Metabolites that Inhibit Cytochrome P450 EnzymesHeather Eng, R Scott Obach
Pageof 20